761.F PHARMANUTRA S.P.A.

Healthcare Pharmaceuticals Frankfurt Exchange
84.20 EUR
Close of Nov 11, 2026
48.93 94.00
Market cap
EUR 806M
P/E
36.8x
P/B
11.22x
ROE
28.5%
Dividend yield
1.19%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is 761.F undervalued?

Graham number

The Graham number of PHARMANUTRA S.P.A. cannot be estimated reliably (the estimate is too far from the market price).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

PHARMANUTRA S.P.A. fundamental analysis

No fundamental analysis for PHARMANUTRA S.P.A. yet.

PHARMANUTRA S.P.A. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About PHARMANUTRA S.P.A.

Pharmanutra S.p.A., a nutraceutical company, engages in the research and development and marketing of food supplements and medical devices in Europe, the Middle East, Far East, North America, South America, and internationally. The company produces and distributes raw materials and active ingredients for the food, pharmaceutical, and dietary supplement industries. It offers Sucrosomial, a delivery system that optimises nutrient transport and absorption for minimising gastroi…

Full company profile